Buscar resultados de ensayos clínicos
Pharyngeal Neoplasms - 100 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Integrated Cancer Repository for Cancer Research Condición:
|
Recruiting |
Nombre del estudio: 18F FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy Condición:
|
Recruiting |
Nombre del estudio: Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck Condición:
|
Active, not recruiting |
Nombre del estudio: Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. Condición:
|
Withdrawn |
Nombre del estudio: Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract Condición:
Intervenciones: |
Completed |
Nombre del estudio: Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy Condición: Nasopharyngeal Neoplasms Fecha: 2008-02-25 Intervenciones: Drug: Pemetrexed (Alimta) 500 mg/m2 in Cycle 1, every 3 weeks, with folic acid and vitamin B12 supplemen |
Completed |
Nombre del estudio: Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Condición: Nasopharyngeal Neoplasms Fecha: 2008-09-04 Intervenciones: Drug: Sorafenib plus Cisplatin and 5-fluorouracil Sorafeni |
Not yet recruiting |
Nombre del estudio: Measuring Patient-Reported Adverse Events in Oncology Practice Improves Quality of Life in Nasopharyngeal Carcinoma Condición: Nasopharyngeal Neoplasms Fecha: 2017-03-16 Intervenciones:
|
Recruiting |
Nombre del estudio: A Trial of Endostar in Patients With Carcinoma of the Head and Neck Condición: Nasopharyngeal Neoplasms Fecha: 2016-08-12 Intervenciones: Drug: Endostar The patients will be randomized to CRT arm and CRT+Endostar arm. All patients will receiv |
Recruiting |
Nombre del estudio: Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122, KEYNOTE-122) Condición: Fecha: 2024-05-19 |